Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 6.24
+0.29 (4.87%)
Aug 21, 2026, 3:28 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 517.38 million as of August 21, 2026. Its market cap has increased by 26.06% in one year.
Market Cap
517.38M
Enterprise Value
4.48B
Revenue
763.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.24
ChartMarket Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 517.38M, a decrease of -50.25%. That is a compound annual growth rate of -3.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 517.38M | -64.69% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 11.48B |
| Amanta Healthcare | 6.72B |
| Bafna Pharmaceuticals | 5.74B |
| Valiant Laboratories | 5.20B |
| Nectar Lifesciences | 2.03B |
| Brooks Laboratories | 1.77B |
| Alpa Laboratories | 1.32B |
| Par Drugs and Chemicals | 1.25B |